Taken together, these data demonstrate that, in CLL B-lymphocytes, BTK has a critical role in CXCL12-triggered inside-out signaling governing integrin affinity upregulation, and that RhoA activation is regulated by BTK. Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.